<DOC>
	<DOC>NCT01207115</DOC>
	<brief_summary>To compare the analgesic efficacy and safety of ABT-652 administered twice daily (BID) to placebo in subjects with osteoarthritis (OA) of the knee.</brief_summary>
	<brief_title>A Study of ABT-652 in Adults With Osteoarthritis Pain of the Knee</brief_title>
	<detailed_description />
	<mesh_term>Osteoarthritis</mesh_term>
	<mesh_term>Osteoarthritis, Knee</mesh_term>
	<mesh_term>Naproxen</mesh_term>
	<criteria>Inclusion Criteria History of OA of the knee joint and meeting American College of Rheumatology (ACR) Clinical and Radiographic criteria, Pain score as required by the protocol at Screening and Baseline Willing to washout of analgesics and to follow treatment plan, visit schedules and study procedures. Exclusion Criteria History of sensitivity to histamine medications, acetaminophen (paracetamol), or nonsteroidal antiinflammatory drugs (NSAIDs) Active gastrointestinal (GI) disease, GI bleeding or GI ulceration, or history of GI bleeding or GI ulceration in the last 6 months History of major psychiatric disorders Diagnosis of rheumatoid arthritis, autoimmune disorder, arthritis other than osteoarthritis involving the study joint, or other painful syndrome that could interfere with the assessment of pain at the study joint Any cardiac, respiratory, neurological or other medical condition or illness that is not well controlled with treatment</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>